evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/geneAliases/9,gene/geneAliases/10,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract
19521,GENE_BACKGROUND,,"MAP2K4 (mitogen-activated protein kinase kinase 4) encodes a dual specificity kinase that directly phosphorylates and activates JNK (c-Jun N-terminal kinase) and p38 MAP kinase (PMID: 7716521). MAP2K4 itself is phosphorylated by one of several upstream MAP kinase kinase kinases (MAPKKK). The activation of JNK and p38 MAP kinase pathways occurs in response to a variety of environmental stressors, such as DNA damage, hypoxia, heat shock, ionizing radiation, as well also inflammatory cytokines and growth factors. The downstream effect is altered transcriptional activity of c-Jun, p53, ELK1, ATF2 and several other transcription factors involved in apoptosis, cell survival, growth and differentiation (PMID: 17496914,19629069). The function of MAP2K4 as a tumor suppressor in primary cancers is supported by multiple reports of inactivating mutations in several tumor cell lines and human cancers at a rate of ~5% (PMID: 9331070, 9622070, 17496914, 22522925). Loss of heterozygosity of the 17p chromosomal region, where MAP2K4 is located in close proximity to TP53, is observed at a much higher frequency in many cancers (PMID: 16721048, 16627982, 19603523). In addition, MAP2K4 has been found to act as a metastatic suppressor in metastatic prostate and ovarian cell lines (PMID: 10554023, 12438272). However, the role of MAP2K4 in tumorigenesis remains controversial and appears to be context-dependent, as there is evidence for MAP2K4 pro-oncogenic activity in breast, pancreatic, skin and lung tumors (PMID:15184866, 20610622,16115952,17057737), as well as pro-metastatic activity in prostate cancer and pancreatic cancers (PMID: 25019290,16740690).",,2017-04-04,,6416,MAP2K4,mitogen-activated protein kinase kinase 4,False,ENST00000353533,NM_003010.3,MKK4,SAPKK1,SERK1,MEK4,JNKK,MAPKK4,PRKMK4,SKK1,JNKK1,SAPKK-1,SEK1,True,25019290,Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis.,PloS one,2014,9,7,e102289,Pavese JM et al,doi: 10.1371/journal.pone.0102289,,Pavese JM et al. PloS one. 2014;9(7)e102289.,,9331070,Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.,Cancer research,0001-10-01,57,19,4177-82,Teng DH et al,,,0001-10-01,,16627982,Homozygous deletion of MKK4 in ovarian serous carcinoma.,Cancer biology &amp; therapy,2018-06-01T20:06:00,5,6,630-4,Nakayama K et al,,,0001-06-01,,7716521,0001-06-01,"Science (New York, N.Y.)",0001-04-14,268,5208,286-90,Lin A et al,,,0001-04-14,,17057737,c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.,Oncogene,2018-04-19T20:07:00,26,18,2658-66,Khatlani TS et al,,,0001-04-19,,12438272,Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.,Cancer research,2018-11-15T20:02:00,62,22,6717-23,Yamada SD et al,,,0001-11-15,,20610622,The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer.,Cancer research,2018-07-15T20:10:00,70,14,5797-806,Finegan KG et al,doi: 10.1158/0008-5472.CAN-09-3669,,2018-07-15T08:06:00,,9622070,"Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.",Cancer research,0001-06-01,58,11,2339-42,Su GH et al,,,0001-06-01,,16721048,Theoretical proposal: allele dosage of MAP2K4/MKK4 could rationalize frequent 17p loss in diverse human cancers.,"Cell cycle (Georgetown, Tex.)",2018-05-01T20:06:00,5,10,1090-3,Cunningham SC et al,,,0001-05-01,,19603523,Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.,"Genes, chromosomes &amp; cancer",2018-10-01T20:09:00,48,10,931-42,Gorringe KL et al,doi: 10.1002/gcc.20694,,0001-10-01,,22522925,"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.",Nature,2018-04-18T20:12:00,486,7403,346-52,Curtis C et al,doi: 10.1038/nature10983,,0001-04-18,,16115952,Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-08-15T20:05:00,11,16,6065-74,Lee HY et al,,,0001-08-15,,10554023,"Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.",Cancer research,0001-11-01,59,21,5483-7,Yoshida BA et al,,,0001-11-01,,15184866,Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.,Oncogene,2018-08-05T20:04:00,23,35,5978-85,Wang L et al,,,0001-08-05,,16740690,Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.,Cancer research,2018-06-01T20:06:00,66,11,5560-4,Cunningham SC et al,,,0001-06-01,,17496914,Role of mitogen-activated protein kinase kinase 4 in cancer.,Oncogene,2018-05-14T20:07:00,26,22,3172-84,Whitmarsh AJ et al,,,0001-05-14,,19629069,Signal integration by JNK and p38 MAPK pathways in cancer development.,Nature reviews. Cancer,2018-08-01T20:09:00,9,8,537-49,Wagner EF et al,doi: 10.1038/nrc2694,,0001-08-01,
19520,GENE_SUMMARY,,"MAP2K4 encodes an intracellular kinase and component of the pro-oncogenic MAP-kinase and JNK signaling pathways. The role of MAP2K4 in tumorigenesis is context-dependent, as it can function as both an oncogene and tumor suppressor.",,2017-04-04,,6416,MAP2K4,mitogen-activated protein kinase kinase 4,False,ENST00000353533,NM_003010.3,MKK4,SAPKK1,SERK1,MEK4,JNKK,MAPKK4,PRKMK4,SKK1,JNKK1,SAPKK-1,SEK1,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
